Private Equity
The ‘real’ story behind fees and their evolution were among topics PEI discussed in Sacramento recently with CalSTRS’ head of private equity, Margot Wirth.
4 min read · 16 November 2015
Kristin Newhall, formerly a partner at The Riverside Company, will fill a new position at High Road overseeing investor relations and administration, including human resources responsibilities.
1 min read · 12 November 2015
The retirement system said it is restructuring and rebalancing its private equity programme, including upping its focus on customised investment accounts and co-investments. As part of this effort, it has already reduced its number of GPs from 132 to 100.
2 min read · 11 November 2015
Ridgemont Equity Partners II is larger than its $735m predecessor, but will follow the same strategy as REP I seeking buyout and growth equity investments of $25m-$100m in sectors including energy, healthcare, TMT and basic industries and services.
2 min read · 11 November 2015
Bain Capital principal Jeff Schwartz tells Private Equity International that the firm’s decision to build the QuVa Pharma platform that manufactures sterile pharmaceutical products for hospitals, was a response to changes to FDA regulation.
2 min read · 09 November 2015
The Canadian firm’s Firethorn fund is the first in a series that will take commitments from individual investors, family offices and smaller institutional investors.
1 min read · 06 November 2015
The AMG Pantheon Fund is “designed to be a one-stop shopping experience for the individual investor who can put up as little as $25,000,” Pantheon MD Kevin Albert said. The fund's portfolio will be composed of investments in primaries, secondaries and co-investments across geographies, managers, sectors, stages and vintages.
3 min read · 06 November 2015
Revelstoke’s co-founder and managing partner Dale Meyer talks to <span class="ITALIC">Private Equity International</span> about investing on a deal-by-deal basis and what it means for the firm to launch its debut fund.
2 min read · 05 November 2015
Hamilton Lane’s previous secondaries fund, Hamilton Lane Secondary Opportunity Fund III, launched in 2012 and exceeded its $650 million target, closing on $900 million in September 2013.
1 min read · 04 November 2015
The firm intends combine its Precyse business with MedAssets Revenue Cycle Management segment, and sell off other parts of the company.
1 min read · 04 November 2015
